SANGAMO THERAPEUTICS, INC (41) | Uncategorized (11)
Recent Contracts
-
Letter Agreement between the Company and David Mark McClung dated November 1, 2021
(Filed With SEC on February 24, 2022)
-
Letter Agreement between the Company and
(Filed With SEC on November 4, 2021)
-
Letter Agreement between the Company and
(Filed With SEC on August 5, 2021)
-
Letter Agreement between the Company and
(Filed With SEC on May 4, 2021)
-
Letter Agreement between the Company and
(Filed With SEC on May 4, 2021)
-
Description of
(Filed With SEC on February 24, 2021)
-
Letter Agreement dated as of January 22, 2021 between Sangamo Therapeutics, Inc. and Sung Lee
(Filed With SEC on January 28, 2021)
-
Open Market Sale Agreement, dated August 5, 2020, between Sangamo Therapeutics, Inc. and Jefferies LLC
(Filed With SEC on August 5, 2020)
-
Letter Agreement
(Filed With SEC on August 5, 2020)
-
Form of Indemnity Agreement
(Filed With SEC on May 11, 2020)
-
Description of Securities of the Company
(Filed With SEC on February 28, 2020)
